- Cancer and Blood Diseases (6)
- Diabetes and Endocrinology (5)
- Fetal Care (3)
- Gastroenterology, Hepatology and Nutrition (9)
- Heart (15)
- Mental and Behavioral Health (8)
- Nephrology (2)
- Neurology and Neurosurgery (5)
- Orthopaedics (8)
- Perinatal (2)
- Pulmonary Medicine (6)
- Urology (5)
Search by Keyword
Results (74)
3D Imaging Guidance to Reverse Growth Plate Injury
Discover how Cincinnati Children’s uses 3D imaging to improve precision and outcomes in pediatric physeal bar excision surgery.
Addressing Scholastic and Mental Health Needs in Patients with Cystic Fibrosis
Discover how Cincinnati Children’s CF WELL program is transforming care for children with cystic fibrosis—addressing educational and mental health needs alongside clinical advances.
Advancements Bring New Hope for Sickle Cell Disease
A Phase II clinical trial conducted in Ghana suggests that hydroxyurea — already a treatment offered for the most common form of sickle cell disease — also shows benefits for those with the hemoglobin SC (HbSC) variant of the condition.
Advancing Catheter Ablation for CHD Patients
Cincinnati Children’s is advancing catheter ablation techniques to treat arrhythmias in patients with congenital heart disease.
Advancing Lifesaving Therapies for Myeloid Malignancies
Discover how Cincinnati Children’s is accelerating research and clinical trials to advance therapies for myeloid malignancies across all age groups.
AI and Flight Plans Unite to Improve Patient Outcomes
Cincinnati Children’s explores AI-powered Flight Plans to enhance decision-making and outcomes in pediatric heart care through data-driven, cloud-based tools.
AI Drives Discovery in Pulmonary Biology
Scientists are advancing lung research using AI and computational genomics to decode biology’s multidimensional complexity.
Anesthesia Strategies for Fetoscopic Myelomeningocele (MMC) Repair
Study finds no link between maternal temperature and fetal heart rate during fetoscopic myelomeningocele (MMC) repairs, guiding anesthetic improvements.
Celebrating Excellence and Community at the 2025 AACAP Annual Meeting
The 2025 AACAP Annual Meeting brought together leaders in child and adolescent psychiatry to celebrate achievements, foster collaboration, and share innovations shaping the future of youth mental health.
Cell Therapy Offers Hope for Duchenne Muscular Dystrophy Patients
Cincinnati Children’s leads phase 3 trials of CAP-1002, a cell therapy showing promise for late-stage Duchenne muscular dystrophy patients with limited treatment options.
3333 Burnet Avenue, Cincinnati, Ohio 45229-3026
© 1999-2025 Cincinnati Children's Hospital Medical Center. All rights reserved.
